Web Analytics

3 Latest Announced Rounds

  • $2,200,000
    Pre-Seed

    4 Investors

    Software Development
    Jan 22nd, 2025
  • $347,401
    Seed

    1 Investors

    Biotechnology Research
    Jan 22nd, 2025
  • $12,000,000
    Series A

    3 Investors

    Software Development
    Jan 22nd, 2025
$1,269.37M Raised in 45 Funding Rounds in the past 7 Days - View All

Funding Round Profile

ARTBIO

start up
United States - Cambridge, Massachusetts
  • 08/12/2023
  • Series A
  • $90,000,000

ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.


Related People

Emanuele OstuniFounder

Emanuele Ostuni Switzerland - Reinach, Basel-Country

Specialties: Commercial execution, Strategy, M&A, Business Development, Entrepreneurship,